In the U.S., asthma inhalers can be three times more expensive than they are in Canada — with most of the cost borne by insurers and the government. Generic versions would be a lot cheaper, but they're off the market despite the fact that asthma afflicts 1 in 11 children and 1 in 12 adults.
↧